Other countries can spot new variants because they’re actively looking for them. But the U.S. has spent a year with its head in the sand. More
Bio & Life Sciences Healthcare
Research Project Seeks Cancer’s Achilles Heel
By looking at cancer as an engineering problem instead of a medical one, scientists are homing in on vulnerabilities that may lead to new ways to knock out tumors. More
Bio & Life Sciences Healthcare The Pandemic
mRNA Vaccines for COVID-19: What You Need to Know
Pfizer and Moderna's astonishingly promising vaccines were made possible by a new scientifiic approach. Here’s a primer on how mRNA vaccines work and why we need them now. More
Bio & Life Sciences The Pandemic
COVID-19 Testing: Good, Bad, and Downright Frustrating
Even dramatically increased testing capacity has been no match for poor strategy and misdirected deployment of tests in the U.S. More
Analytics & Data Bio & Life Sciences The Pandemic
Could a Schizophrenia Treatment Conquer COVID-19?
Scientists are analyzing previously approved drugs to see if they have any effect against the SARS-CoV-2 virus. They might be onto something. More
Bio & Life Sciences Healthcare Resilience Techonomy Events
Making the World a Healthier Place through Digital Health
Moderated by W2O’s Aaron Strout, panel participants include Melissa Opraseuth, Chief Operating Officer at par8o and Jennifer Lavanture, Vice President of Business Development at MedRhythms. Panelists will discuss how the technology’s promise of advancing healthcare is being realized at both their companies and how this sector will evolve over the next couple of years. More
Analytics & Data Bio & Life Sciences Healthcare
How Google Thinks About Digital Health
A leader in some of Alphabet’s health-focused initiatives recently offered an update on ways the search and data giant can use information and digital tools to improve outcomes for individuals and society. More
Bio & Life Sciences The Pandemic
Science Is What Determined a Successful Public Response to COVID-19
Some leaders saw that flattening the curve wouldn’t work against the pandemic. Others were reluctant to test at all. Scientific data made the difference between responses that worked, and those that didn’t. More
Bio & Life Sciences Healthcare The Pandemic
Five Things Genomics Has Taught Us About COVID-19
‘Everything is unprecedented about the pandemic, and genomics is no exception,’ says an infectious disease expert. Genome sequencing has enabled scientists to track the virus, study its origins, confirm reinfection, and get to know more about it than has been learned about any organism in such a short time. More
Bio & Life Sciences Community Insights Global Tech
We Need a New International Organization: The Science Readiness Reserves
COVID-19 is a wake-up call for institutional renewal and reform. The only way to face the uncertainties of the future is to build more, stronger public-private partnerships, and on a global basis. More
Bio & Life Sciences Healthcare Innovation
Your Camera Knows You’re the Picture of Health–or If You Have COVID
Several companies are developing technology that can read your vital signs (and screen for COVID) via your smartphone camera simply by looking at your face. More
Bio & Life Sciences Healthcare
Science Association Chief Very Worried about COVID’s Impact on Research
The president of the American Association for the Advancement of Science says the pandemic’s toll on non-COVID science is ‘a huge hit.’. Many research studies shut down midway, possibly turning results into a total loss. More
Bio & Life Sciences Healthcare
For All Its Promise, Genomic Testing Is Struggling
For both clinical and consumer markets, genomic testing has a lot to offer — but it isn’t always used where it could be valuable, and people don’t understand it well enough. As a result, demand is dwindling in some areas. More
Bio & Life Sciences Healthcare The Pandemic
A COVID Vaccine? Six Things to Watch
A good COVID-19 vaccine is the game-changer we all want and need. Here are six things to watch as the process unfolds. More
Bio & Life Sciences Healthcare Science
How America’s Low Science Literacy Fueled the COVID Crisis
Americans have an uneasy relationship with science, and it’s influenced our sorry response to the COVID-19 pandemic. What could we do to improve the situation? More
Bio & Life Sciences Healthcare Mobile
Why Americans Hate Contact Tracing
Americans are about as likely to report they’ve had Covid-19 and turn over their contacts as they are to report they’ve got head lice or STDs. More
Bio & Life Sciences Innovation Manufacturing
Broaden Your View of Biology– It Could Soon Drive $4 Trillion in Value
A new report on the “bio revolution” finds that bio-based production of goods will have major economic impact over the next 20 years, and help combat climate change. More
Bio & Life Sciences Healthcare
Genetic Counselors Embrace Tech to Help More Patients
To meet demand for interpretation of genetic tests, counselors are turning to chatbots, telemedicine, and more. A new grant opportunity from the NIH is another major boost. More
Bio & Life Sciences Healthcare Internet of Things
Now Every Doctor’s a “Teledoc” But What’s Next?
Before the pandemic less than 10% of the American population had tried telehealth services. Most of us felt telehealth generally wasn’t much more than a doctor-directed self examination. “Where does it hurt? Do you have a fever? ” A typical session via companies like Teladoc, Amwell or HealthTap took 15 minutes and cost something like […] More
Bio & Life Sciences Healthcare
As We Wait For a Vaccine, Scientists Eye Antibodies
Antibody-based therapies may pave the way out of pandemic lockdown regardless of how soon a vaccine is available. ‘The science has been really blazing fast,’ says one expert. More
Newsletter